The beta‐cell in type 1 diabetes: What have we learned from proteomic studies?

Publisher： John Wiley & Sons Inc

E-ISSN： 1862-8354|9|7-8|755-766

ISSN： 1862-8346

Source： PROTEOMICS - CLINICAL APPLICATIONS, Vol.9, Iss.7-8, 2015-08, pp. : 755-766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Mutations in Cell Adhesion Genes: What Have We Learned from Them?

By Hynes R.O.  

Developmental Biology, Vol. 180, Iss. 2, 1996-12 ,pp. : 402-412

Academic Press

Access to resources Recommend Favorite

The Hedgehog Signalling Pathway in Cell Migration and Guidance: What We Have Learned from Drosophila melanogaster

By Araújo Sofia J.  

Cancers, Vol. 7, Iss. 4, 2015-10 ,pp. : 2012-2022

MDPI

Access to resources Recommend Favorite

A proteomic study of the regulatory role for STAT‐1 in cytokine‐induced beta‐cell death

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 9-10, 2015-10 ,pp. : 938-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

A proteomic study of the regulatory role for STAT‐1 in cytokine‐induced beta‐cell death

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 1862-8346, Iss. 9-10, 2015-10 ,pp. : 938-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induced Pluripotent Stem Cell Modeling of Gaucher’s Disease: What Have We Learned?

By Santos Dino Matias   Tiscornia Gustavo  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 888-888

MDPI

Access to resources Recommend Favorite